0.2405
price down icon3.68%   -0.0092
after-market Handel nachbörslich: .24 -0.0005 -0.21%
loading

Processa Pharmaceuticals Inc Aktie (PCSA) Neueste Nachrichten

pulisher
08:57 AM

What analysts say about Processa Pharmaceuticals Inc. stockExceptional profit potential - Autocar Professional

08:57 AM
pulisher
03:05 AM

Processa Pharmaceuticals Inc. Stock Analysis and ForecastRecord-breaking capital gains - jammulinksnews.com

03:05 AM
pulisher
Jul 22, 2025

Processa Pharmaceuticals Inc (PCSA) Stock: A Year of Stock Market Dynamics - investchronicle.com

Jul 22, 2025
pulisher
Jul 22, 2025

What drives Processa Pharmaceuticals Inc. stock priceUnbelievable profit margins - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 22, 2025

What makes Processa Pharmaceuticals Inc. stock price move sharplyFree Wealth-Building Investment Strategies - Newser

Jul 22, 2025
pulisher
Jul 19, 2025

Is Processa Pharmaceuticals Inc. a good long term investmentRecord-breaking gains - Autocar Professional

Jul 19, 2025
pulisher
Jul 19, 2025

Processa Pharmaceuticals Approves Key Proposals at Annual Meeting - The Globe and Mail

Jul 19, 2025
pulisher
Jul 18, 2025

RedChip Showcases Processa Pharmaceuticals and BullFrog AI on Bloomberg TV - AInvest

Jul 18, 2025
pulisher
Jul 18, 2025

Processa Pharmaceuticals and BullFrog AI Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV - The Des Moines Register

Jul 18, 2025
pulisher
Jul 18, 2025

The Convergence of AI and Biotech: BullFrog AI and Processa Pharmaceuticals as Catalysts for Disruption - AInvest

Jul 18, 2025
pulisher
Jul 16, 2025

How Processa Pharmaceuticals Inc. stock performs during market volatilityTrend Following Trades - Newser

Jul 16, 2025
pulisher
Jul 15, 2025

Why Processa Pharmaceuticals Inc. stock attracts strong analyst attentionCarefully Curated High Return Stocks - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

Processa Pharmaceuticals Reschedules Annual Shareholder Meeting - TipRanks

Jul 15, 2025
pulisher
Jul 15, 2025

Processa Pharmaceuticals to reconvene annual meeting after achieving quorum By Investing.com - Investing.com South Africa

Jul 15, 2025
pulisher
Jul 15, 2025

Processa Pharmaceuticals to reconvene annual meeting after achieving quorum - Investing.com

Jul 15, 2025
pulisher
Jul 13, 2025

Processa Pharmaceuticals, Inc. (PCSA) Secures Buy Rating on Portfolio Progress - MSN

Jul 13, 2025
pulisher
Jul 11, 2025

Processa Pharmaceuticals: Betting on Catalyst-Driven Value Acceleration - AInvest

Jul 11, 2025
pulisher
Jul 09, 2025

Processa Stock Soars 33.96% on Penny Stock Inclusion - AInvest

Jul 09, 2025
pulisher
Jul 09, 2025

Processa Stock Soars 14.62% on Penny Stock Inclusion - AInvest

Jul 09, 2025
pulisher
Jul 08, 2025

12 Best Fundamentally Strong Penny Stocks to Invest in - Insider Monkey

Jul 08, 2025
pulisher
Jul 03, 2025

HC Wainwright Has Positive Estimate for Heatwurx Q2 Earnings - Defense World

Jul 03, 2025
pulisher
Jul 02, 2025

Processa terminates license agreement for PCS3117 - TipRanks

Jul 02, 2025
pulisher
Jul 01, 2025

Processa Pharmaceuticals adjourns annual meeting due to lack of quorum By Investing.com - Investing.com UK

Jul 01, 2025
pulisher
Jun 30, 2025

Processa Pharmaceuticals adjourns annual meeting due to lack of quorum - Investing.com

Jun 30, 2025
pulisher
Jun 30, 2025

Processa Pharmaceuticals Adjourns Annual Shareholder Meeting - TipRanks

Jun 30, 2025
pulisher
Jun 23, 2025

Processa Pharmaceuticals Plunges 15.31% Amid Market Volatility - AInvest

Jun 23, 2025
pulisher
Jun 20, 2025

Rx Rundown: Sanofi, Processa Pharmaceuticals, Eli Lilly and more - Medical Marketing and Media

Jun 20, 2025
pulisher
Jun 18, 2025

Processa Pharmaceuticals Announces Public Offering Pricing - TipRanks

Jun 18, 2025
pulisher
Jun 18, 2025

Processa inks licensing deal with Intact for gastroparesis drug By Investing.com - Investing.com India

Jun 18, 2025
pulisher
Jun 18, 2025

Processa Pharmaceuticals Announces Pricing of $7 Million Public Offering - The Manila Times

Jun 18, 2025
pulisher
Jun 17, 2025

Processa Pharmaceuticals (PCSA) Sets Public Offering Price at $0 - GuruFocus

Jun 17, 2025
$22.87
price up icon 4.91%
$36.01
price down icon 0.25%
$103.44
price up icon 0.51%
$28.01
price up icon 5.54%
$114.60
price up icon 2.84%
biotechnology ONC
$294.83
price down icon 0.26%
Kapitalisierung:     |  Volumen (24h):